The Antisense & RNAi Therapeutics market revenue was 1415.15 Million USD in 2022, and will reach 2078.9 Million USD in 2028, with a CAGR of 6.62% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Antisense & RNAi Therapeutics industry, and breaks down according to the type, application, and consumption area of Antisense & RNAi Therapeutics. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Antisense & RNAi Therapeutics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Antisense & RNAi Therapeutics market covered in Chapter 11:
Dicerna Pharmaceuticals
Arbutus Biopharma Ltd.
Sanofi Aventis / Genzyme
Calando Pharmaceuticals
Quark Pharmaceuticals
Biomarin/Prosensa
Rxi Pharmaceuticals
Rexhan Pharmaceuticals
ICo Therapeutics
Silence Therapeutics
Glaxo Smith Kline
Silenseed
Bio-Path Holdings Inc.
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Regulus Therapeutics
In Chapter 3, on the basis of types, the Antisense & RNAi Therapeutics market from 2018 to 2028 is primarily split into:
RNA interference
SiRNA
MiRNA
Antisense RNA
In Chapter 4, on the basis of applications, the Antisense & RNAi Therapeutics market from 2018 to 2028 covers:
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028
Global Antisense & RNAi Therapeutics Market Insights: Impact of COVID-19 and Future Expectations to 2028
Table of Content
1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic
2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain
3 Global Antisense & RNAi Therapeutics Market, By Product Type
3.1 Global Antisense & RNAi Therapeutics Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Global Antisense & RNAi Therapeutics Sales and Market Share by Types (2018-2023)
3.1.2 Global Antisense & RNAi Therapeutics Revenue and Market Share by Types (2018-2023)
3.1.3 Global Antisense & RNAi Therapeutics Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Global Antisense & RNAi Therapeutics Sales, Price and Growth Rate of RNA interference (2018-2023)
3.4 Global Antisense & RNAi Therapeutics Sales, Price and Growth Rate of SiRNA (2018-2023)
3.5 Global Antisense & RNAi Therapeutics Sales, Price and Growth Rate of MiRNA (2018-2023)
3.6 Global Antisense & RNAi Therapeutics Sales, Price and Growth Rate of Antisense RNA (2018-2023)
4 Global Antisense & RNAi Therapeutics Market, By Applications
4.1 Global Antisense & RNAi Therapeutics Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Global Antisense & RNAi Therapeutics Consumption and Market Share by Applications (2018-2023)
4.1.2 Global Antisense & RNAi Therapeutics Revenue and Market Share by Applications (2018-2023)
4.2 Oncology
4.3 Cardiovascular
4.4 Renal
4.5 Neurodegenerative
4.6 Respiratory
4.7 Genetic
4.8 Infectious Diseases
5 Global Antisense & RNAi Therapeutics Market, By Regions
5.1 Global Antisense & RNAi Therapeutics Market Sales and Market Share by Regions
5.1.1 Global Antisense & RNAi Therapeutics Sales by Regions (2018-2023)
5.1.2 Global Antisense & RNAi Therapeutics Sales Market Share by Regions (2018-2023)
5.2 Global Antisense & RNAi Therapeutics Market Revenue and Market Share by Regions
5.2.1 Global Antisense & RNAi Therapeutics Revenue by Regions (2018-2023)
5.2.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis
6 North America Antisense & RNAi Therapeutics Market Analysis
6.1 North America Antisense & RNAi Therapeutics Market Size
6.1.1 North America Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
6.1.2 North America Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
6.2 U.S. Antisense & RNAi Therapeutics Market Size
6.3 Canada Antisense & RNAi Therapeutics Market Size
6.4 Mexico Antisense & RNAi Therapeutics Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market
7 Europe Antisense & RNAi Therapeutics Market Analysis
7.1 Europe Antisense & RNAi Therapeutics Market Size
7.1.1 Europe Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
7.1.2 Europe Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
7.2 Germany Antisense & RNAi Therapeutics Market Size
7.3 United Kingdom Antisense & RNAi Therapeutics Market Size
7.4 France Antisense & RNAi Therapeutics Market Size
7.5 Italy Antisense & RNAi Therapeutics Market Size
7.6 Spain Antisense & RNAi Therapeutics Market Size
7.7 Russia Antisense & RNAi Therapeutics Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market
8 Asia-Pacific Antisense & RNAi Therapeutics Market Analysis
8.1 Asia-Pacific Antisense & RNAi Therapeutics Market Size
8.1.1 Asia-Pacific Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
8.2 China Antisense & RNAi Therapeutics Market Size
8.3 Japan Antisense & RNAi Therapeutics Market Size
8.4 South Korea Antisense & RNAi Therapeutics Market Size
8.5 Australia Antisense & RNAi Therapeutics Market Size
8.6 India Antisense & RNAi Therapeutics Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market
9 Middle East and Africa Antisense & RNAi Therapeutics Market Analysis
9.1 Middle East and Africa Antisense & RNAi Therapeutics Market Size
9.1.1 Middle East and Africa Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia Antisense & RNAi Therapeutics Market Size
9.3 UAE Antisense & RNAi Therapeutics Market Size
9.4 Egypt Antisense & RNAi Therapeutics Market Size
9.5 South Africa Antisense & RNAi Therapeutics Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market
10 South America Antisense & RNAi Therapeutics Market Analysis
10.1 South America Antisense & RNAi Therapeutics Market Size
10.1.1 South America Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
10.1.2 South America Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
10.2 Brazil Antisense & RNAi Therapeutics Market Size
10.3 Argentina Antisense & RNAi Therapeutics Market Size
10.4 Columbia Antisense & RNAi Therapeutics Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market
11 Competition Landscape and Company Profiles
11.1 Dicerna Pharmaceuticals
11.1.1 Dicerna Pharmaceuticals Basic Information
11.1.2 Dicerna Pharmaceuticals Product Profiles, Application and Specification
11.1.3 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.2 Arbutus Biopharma Ltd.
11.2.1 Arbutus Biopharma Ltd. Basic Information
11.2.2 Arbutus Biopharma Ltd. Product Profiles, Application and Specification
11.2.3 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.3 Sanofi Aventis / Genzyme
11.3.1 Sanofi Aventis / Genzyme Basic Information
11.3.2 Sanofi Aventis / Genzyme Product Profiles, Application and Specification
11.3.3 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.4 Calando Pharmaceuticals
11.4.1 Calando Pharmaceuticals Basic Information
11.4.2 Calando Pharmaceuticals Product Profiles, Application and Specification
11.4.3 Calando Pharmaceuticals Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.5 Quark Pharmaceuticals
11.5.1 Quark Pharmaceuticals Basic Information
11.5.2 Quark Pharmaceuticals Product Profiles, Application and Specification
11.5.3 Quark Pharmaceuticals Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.6 Biomarin/Prosensa
11.6.1 Biomarin/Prosensa Basic Information
11.6.2 Biomarin/Prosensa Product Profiles, Application and Specification
11.6.3 Biomarin/Prosensa Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.7 Rxi Pharmaceuticals
11.7.1 Rxi Pharmaceuticals Basic Information
11.7.2 Rxi Pharmaceuticals Product Profiles, Application and Specification
11.7.3 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.8 Rexhan Pharmaceuticals
11.8.1 Rexhan Pharmaceuticals Basic Information
11.8.2 Rexhan Pharmaceuticals Product Profiles, Application and Specification
11.8.3 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.9 ICo Therapeutics
11.9.1 ICo Therapeutics Basic Information
11.9.2 ICo Therapeutics Product Profiles, Application and Specification
11.9.3 ICo Therapeutics Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.10 Silence Therapeutics
11.10.1 Silence Therapeutics Basic Information
11.10.2 Silence Therapeutics Product Profiles, Application and Specification
11.10.3 Silence Therapeutics Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.11 Glaxo Smith Kline
11.11.1 Glaxo Smith Kline Basic Information
11.11.2 Glaxo Smith Kline Product Profiles, Application and Specification
11.11.3 Glaxo Smith Kline Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.12 Silenseed
11.12.1 Silenseed Basic Information
11.12.2 Silenseed Product Profiles, Application and Specification
11.12.3 Silenseed Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.13 Bio-Path Holdings Inc.
11.13.1 Bio-Path Holdings Inc. Basic Information
11.13.2 Bio-Path Holdings Inc. Product Profiles, Application and Specification
11.13.3 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.14 Isis Pharmaceuticals/ Ionis Pharmaceuticals
11.14.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Basic Information
11.14.2 Isis Pharmaceuticals/ Ionis Pharmaceuticals Product Profiles, Application and Specification
11.14.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Market Performance (2018-2023)
11.15 Regulus Therapeutics
11.15.1 Regulus Therapeutics Basic Information
11.15.2 Regulus Therapeutics Product Profiles, Application and Specification
11.15.3 Regulus Therapeutics Antisense & RNAi Therapeutics Market Performance (2018-2023)
12 Global Antisense & RNAi Therapeutics Market Forecast, By Type and Applications
12.1 Global Antisense & RNAi Therapeutics Market Forecast by Types (2023-2028)
12.1.1 Global Antisense & RNAi Therapeutics Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Global Antisense & RNAi Therapeutics Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Global Antisense & RNAi Therapeutics Market Forecast by Applications (2023-2028)
12.2.1 Global Antisense & RNAi Therapeutics Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Global Antisense & RNAi Therapeutics Market Forecast Revenue and Market Share by Applications (2023-2028)
13 Global Antisense & RNAi Therapeutics Market Forecast, By Regions
13.1 Global Antisense & RNAi Therapeutics Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Global Antisense & RNAi Therapeutics Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America Antisense & RNAi Therapeutics Market Forecast (2023-2028)
13.4 Europe Antisense & RNAi Therapeutics Market Forecast (2023-2028)
13.5 Asia-Pacific Antisense & RNAi Therapeutics Market Forecast (2023-2028)
13.6 Middle East and Africa Antisense & RNAi Therapeutics Market Forecast (2023-2028)
13.7 South America Antisense & RNAi Therapeutics Market Forecast (2023-2028)
14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer
List of Tables and Figures
Table Antisense & RNAi Therapeutics Key Market Segments
Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate 2018-2028
Figure Channel Status of Antisense & RNAi Therapeutics
Table Market Driving Factors of Antisense & RNAi Therapeutics
Table Market Industry Constraints and Challenges of Antisense & RNAi Therapeutics
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Global Antisense & RNAi Therapeutics Sales by Types (2018-2023)
Table Global Antisense & RNAi Therapeutics Sales Share by Types (2018-2023)
Table Global Antisense & RNAi Therapeutics Revenue ($) by Types (2018-2023)
Table Global Antisense & RNAi Therapeutics Revenue Share by Types (2018-2023)
Table Global Antisense & RNAi Therapeutics Price by Types (2018-2023)
Figure Global RNA interference Sales and Growth Rate (2018-2023)
Figure Global RNA interference Price (2018-2023)
Figure Global SiRNA Sales and Growth Rate (2018-2023)
Figure Global SiRNA Price (2018-2023)
Figure Global MiRNA Sales and Growth Rate (2018-2023)
Figure Global MiRNA Price (2018-2023)
Figure Global Antisense RNA Sales and Growth Rate (2018-2023)
Figure Global Antisense RNA Price (2018-2023)
Table Global Antisense & RNAi Therapeutics Consumption by Applications (2018-2023)
Table Global Antisense & RNAi Therapeutics Consumption Share by Applications (2018-2023)
Table Global Antisense & RNAi Therapeutics Revenue ($) by Applications (2018-2023)
Table Global Antisense & RNAi Therapeutics Revenue Share by Applications (2018-2023)
Figure Global Oncology Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Cardiovascular Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Renal Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Neurodegenerative Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Respiratory Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Genetic Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Infectious Diseases Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Antisense & RNAi Therapeutics Sales and Growth Rate (2018-2023)
Table Global Antisense & RNAi Therapeutics Sales by Regions (2018-2023)
Table Global Antisense & RNAi Therapeutics Sales Market Share by Regions (2018-2023)
Figure Global Antisense & RNAi Therapeutics Sales Market Share by Regions in 2022
Figure Global Antisense & RNAi Therapeutics Revenue and Growth Rate (2018-2023)
Table Global Antisense & RNAi Therapeutics Revenue by Regions (2018-2023)
Table Global Antisense & RNAi Therapeutics Revenue Market Share by Regions (2018-2023)
Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Regions in 2022
Figure North America Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Table North America Antisense & RNAi Therapeutics Sales by Countries (2018-2023)
Figure North America Antisense & RNAi Therapeutics Market Revenue ($) and Growth Rate (2018-2023)
Table North America Antisense & RNAi Therapeutics Revenue ($) by Countries (2018-2023)
Figure U.S. Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure U.S. Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Canada Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Canada Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Mexico Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Mexico Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Table Europe Antisense & RNAi Therapeutics Sales by Countries (2018-2023)
Figure Europe Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Table Europe Antisense & RNAi Therapeutics Revenue by Countries (2018-2023)
Figure Germany Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Germany Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure United Kingdom Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure France Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure France Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Italy Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Italy Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Spain Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Spain Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Russia Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Russia Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific Antisense & RNAi Therapeutics Sales by Countries (2018-2023)
Figure Asia-Pacific Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries (2018-2023)
Figure China Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure China Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Japan Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Japan Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure South Korea Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure South Korea Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Australia Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Australia Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure India Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure India Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa Antisense & RNAi Therapeutics Sales by Countries (2018-2023)
Figure Middle East and Africa Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Antisense & RNAi Therapeutics Revenue by Countries (2018-2023)
Figure Saudi Arabia Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure UAE Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure UAE Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Egypt Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Egypt Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure South Africa Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure South Africa Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure South America Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Table South America Antisense & RNAi Therapeutics Sales by Countries (2018-2023)
Figure South America Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Table South America Antisense & RNAi Therapeutics Revenue by Countries (2018-2023)
Figure Brazil Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Brazil Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Argentina Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Argentina Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Figure Columbia Antisense & RNAi Therapeutics Market Sales and Growth Rate (2018-2023)
Figure Columbia Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2018-2023)
Table Dicerna Pharmaceuticals Company Profile
Table Dicerna Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Dicerna Pharmaceuticals Production and Growth Rate
Figure Dicerna Pharmaceuticals Value ($) Market Share 2018-2023
Table Arbutus Biopharma Ltd. Company Profile
Table Arbutus Biopharma Ltd. Production, Value, Price, Gross Margin 2018-2023
Figure Arbutus Biopharma Ltd. Production and Growth Rate
Figure Arbutus Biopharma Ltd. Value ($) Market Share 2018-2023
Table Sanofi Aventis / Genzyme Company Profile
Table Sanofi Aventis / Genzyme Production, Value, Price, Gross Margin 2018-2023
Figure Sanofi Aventis / Genzyme Production and Growth Rate
Figure Sanofi Aventis / Genzyme Value ($) Market Share 2018-2023
Table Calando Pharmaceuticals Company Profile
Table Calando Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Calando Pharmaceuticals Production and Growth Rate
Figure Calando Pharmaceuticals Value ($) Market Share 2018-2023
Table Quark Pharmaceuticals Company Profile
Table Quark Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Quark Pharmaceuticals Production and Growth Rate
Figure Quark Pharmaceuticals Value ($) Market Share 2018-2023
Table Biomarin/Prosensa Company Profile
Table Biomarin/Prosensa Production, Value, Price, Gross Margin 2018-2023
Figure Biomarin/Prosensa Production and Growth Rate
Figure Biomarin/Prosensa Value ($) Market Share 2018-2023
Table Rxi Pharmaceuticals Company Profile
Table Rxi Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Rxi Pharmaceuticals Production and Growth Rate
Figure Rxi Pharmaceuticals Value ($) Market Share 2018-2023
Table Rexhan Pharmaceuticals Company Profile
Table Rexhan Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Rexhan Pharmaceuticals Production and Growth Rate
Figure Rexhan Pharmaceuticals Value ($) Market Share 2018-2023
Table ICo Therapeutics Company Profile
Table ICo Therapeutics Production, Value, Price, Gross Margin 2018-2023
Figure ICo Therapeutics Production and Growth Rate
Figure ICo Therapeutics Value ($) Market Share 2018-2023
Table Silence Therapeutics Company Profile
Table Silence Therapeutics Production, Value, Price, Gross Margin 2018-2023
Figure Silence Therapeutics Production and Growth Rate
Figure Silence Therapeutics Value ($) Market Share 2018-2023
Table Glaxo Smith Kline Company Profile
Table Glaxo Smith Kline Production, Value, Price, Gross Margin 2018-2023
Figure Glaxo Smith Kline Production and Growth Rate
Figure Glaxo Smith Kline Value ($) Market Share 2018-2023
Table Silenseed Company Profile
Table Silenseed Production, Value, Price, Gross Margin 2018-2023
Figure Silenseed Production and Growth Rate
Figure Silenseed Value ($) Market Share 2018-2023
Table Bio-Path Holdings Inc. Company Profile
Table Bio-Path Holdings Inc. Production, Value, Price, Gross Margin 2018-2023
Figure Bio-Path Holdings Inc. Production and Growth Rate
Figure Bio-Path Holdings Inc. Value ($) Market Share 2018-2023
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Company Profile
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Isis Pharmaceuticals/ Ionis Pharmaceuticals Production and Growth Rate
Figure Isis Pharmaceuticals/ Ionis Pharmaceuticals Value ($) Market Share 2018-2023
Table Regulus Therapeutics Company Profile
Table Regulus Therapeutics Production, Value, Price, Gross Margin 2018-2023
Figure Regulus Therapeutics Production and Growth Rate
Figure Regulus Therapeutics Value ($) Market Share 2018-2023
Table Global Antisense & RNAi Therapeutics Market Forecast Sales by Types (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Sales Share by Types (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Revenue ($) by Types (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Revenue Share by Types (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Consumption by Applications (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Consumption Share by Applications (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Revenue ($) by Applications (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Revenue Share by Applications (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Sales by Regions (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Sales Share by Regions (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Revenue ($) by Regions (2023-2028)
Table Global Antisense & RNAi Therapeutics Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Global Surgical Overalls Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030.
According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
Global Medical or Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
Global Hospital Gas Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Nurse Call Systems Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 135
According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period.
The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
Global Pediatric Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 118
According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 100
Market Overview of Global Telepharmacy market:
According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Vinca Alkaloid Compounds market:
According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 116
Market Overview of Global Bladder Cancer market:
According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years.
Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market:
According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
